Stock ORMP ORAMED PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Oramed Pharmaceuticals Inc.

Equities

ORMP

US68403P2039

Real-time Estimate Cboe BZX
Other stock markets
 12:33:20 2024-06-12 pm EDT 		5-day change 1st Jan Change
2.375 USD +14.73% Intraday chart for Oramed Pharmaceuticals Inc. +6.35% +1.74%
01:14pm Scilex Holding Signs Commitment Letter for $100 Million Financing; Shares Advance Premarket MT
Jun. 10 Oramed Pharmaceuticals Inc. Appoints Mr. Avraham Gabay as Chief Financial Officer, Effective as of June 18, 2024 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oramed Pharmaceuticals Inc. Appoints Mr. Avraham Gabay as Chief Financial Officer, Effective as of June 18, 2024
CI
Oramed Pharmaceuticals Inc. Appoints Mr. Avraham Gabay as Treasurer and Secretary, Effective as of June 18, 2024
CI
Compugen Names David Silberman CFO
MT
Oramed Pharmaceuticals Inc. Announces Resignation of David Silberman as Treasurer and Secretary, Effective July 12, 2024
CI
Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024
CI
Oramed Pharmaceuticals Inc. Announces Resignation of Yadin Rozov from the Board of Directors
CI
Oramed Pharmaceuticals Inc. Appoints Daniel Aghion as Director, Effective January 1, 2024
CI
Oramed Pharmaceuticals Inc. Appoints Ben Shapiro to Its Board of Directors
CI
Insider Buy: Oramed Pharmaceuticals
MT
Insider Sell: Oramed Pharmaceuticals
MT
Oramed Pharmaceuticals Inc. Appoints Anne Peters to Its Scientific Advisory Board
CI
Oramed Pharmaceuticals Inc Announces Appoints Yadin Rozov to Its Board of Directors
CI
Oramed Pharmaceuticals Inc. Announces the Appointment of Netanel Derovan as Chief Legal Officer (General Counsel) and Company Secretary, Effective January 9, 2022
CI
Insider Sell: Oramed Pharmaceuticals
MT
Oramed Pharmaceuticals Inc. Appoints Michael Rabinowitz as Chief Commercial Officer
CI
Oramed Pharmaceuticals Inc. Appoints David Silberman as Treasurer and Secretary, Effective July 5, 2021
CI
Oramed Pharmaceuticals Inc. Announces Resignation of Avraham Gabay as Treasurer and Secretary Effective July 5, 2021
CI
Oramed Pharmaceuticals Inc. Announces Resignation of Avraham Gabay as Chief Financial Officer, Effective July 5, 2021
CI
Oramed Appoints Dr. Julio Rosenstock to its Scientific Advisory Board
CI
Oramed Pharmaceuticals Inc. Elects Alexander Fleming to Scientific Advisory Board
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ORMP Stock
  4. News Oramed Pharmaceuticals Inc.
  5. Insiders